DelMar Pharmaceuticals Inc (DMPI) is near the top in its industry group according to InvestorsObserver. DMPI gets an overall rating of 46. That means it scores higher than 46 percent of stocks. DelMar Pharmaceuticals Inc gets a 45 rank in the Biotechnology industry. Biotechnology is number 49 out of 148 industries.
Click Here to get the full Stock Score Report on DelMar Pharmaceuticals Inc (DMPI) Stock.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With DelMar Pharmaceuticals Inc Stock Today?
DelMar Pharmaceuticals Inc (DMPI) stock is trading at $0.59 as of 9:54 AM on Wednesday, Jan 29, a rise of $0.05, or 9.24% from the previous closing price of $0.54. The stock has traded between $0.57 and $0.70 so far today. Volume today is elevated. So far 491,957 shares have traded compared to average volume of 244,825 shares.
To see InvestorsObserver's Sentiment Score for DelMar Pharmaceuticals Inc click here.
